 Postmarketing surveillance study of permethrin creme rinseE.B. Andrews, M.C. Joseph, M.J. Magenheim, H.H. Tilson, P.A. Doi and M.W. Schultz American Journal of Public Health, 1992, vol. 82, issue 6, 857-861 Abstract: Background. An observational, epidemiological study was undertaken to evaluate the safety of permethrin 1% creme rinse (Nix(TM)) for treatment of head lice infestations. Methods. Thirty-seven local public health departments enrolled a total of 38 160 patients for 47 578 treatments with permethrin or other pediculicides from September 1, 1986, through January 31, 1988. Follow- up safety information was collected between 7 and 14 days following treatment via return visit or telephone contact. Results. One hundred three adverse events were reported among 41 955 evaluable treatments. The rates of reported adverse events were 2.2 per 1000 treatments among permethrin treatments, 3.4 per 1000 treatments among lindane treatments, and 1.5 per 1000 treatments among other over-the-counter treatments. No serious, unexpected adverse events were detected in the 18 950 patients treated with permethrin. Conclusions. This study confirmed the safety profile of permethrin in conditions of general use, as seen in clinical trials. Postmarketing safety monitoring in public health departments of drugs used to treat public health conditions was shown to be feasible. Date: 1992 There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it. Related works: Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text Persistent link: https://EconPapers.repec.org/RePEc:aph:ajpbhl:1992:82:6:857-861_8 Access Statistics for this article American Journal of Public Health is currently edited by Alfredo Morabia More articles in American Journal of Public Health from American Public Health Association |
Is your work missing from RePEc? Here is how to contribute.
Questions or problems? Check the EconPapers FAQ or send mail to .
EconPapers is hosted by the
School of Business at Örebro University.